Trimeris names new CEO
Executive Summary
Former GlaxoSmithKline Senior VP-Global Commercial Strategy Steven Skolsky takes top leadership slot at Trimeris effective Sept. 9. Skolsky succeeds company founder Dani Bolognesi, PhD, who is staying on as chief scientific officer. Skolsky's appointment fills a need for senior leadership following the departure of Trimeris' President Nixon Ellis, PhD, in June. At GSK, Skolsky's most recent post is being filled by Richard Wallace, who moved up from VP-global therapeutic area strategy for psychiatry...